Journal Watch
-
Adsorptive column removes B2m
Too-high levels of B2m cause amyloidosis in people on dialysis, with joint and bone pain. In Japan, people dialyzed using the Lixelle S-15 adsorptive column had significantly less B2m in their blood after a year of 3x/week treatments. They were also stronger and had less joint pain.
Read the abstract » | (added 2011-11-28)
Tags: Chronic kidney disease
-
Yes, PD can be done with diabetes
PD is gentle on the blood vessels. With use of icodextrin and other steps to optimize glucose and volume control, it can be a good option for those with diabetes.
Read the abstract » | (added 2011-11-28)
Tags:
-
Eating more protein linked with longer life on PD
In a study of 305 people on PD, those who ate the most protein (≥0.94 g/kg/day) were stronger and at less risk for heart disease, peritonitis, and death than those who ate the less.
Read the abstract » | (added 2011-11-28)
Tags:
-
Protein intake improves after a switch from standard to nocturnal HD
After 8 months of nocturnal HD, 15 people who switched from standard in-center HD had significantly higher protein intake. Their phosphate intake rose as well—but their serum phosphate levels did not, even without binders.
Read the abstract » | (added 2011-11-28)
Tags:
-
Alternate-night HD improves bone minerals & blood pressure
Among 63 people in Australia who switched from standard HD to alternate-night HD, bone mineral balance and blood pressure improved after 18–24 months. Left ventricular mass did not improve, but remained stable.
Read the abstract » | (added 2011-11-28)
Tags:
-
Home dialysis boosts patient employment in Finland
A new study looked at employment results among 2,637 people ages 15 to 64 on dialysis or with kidney transplants in Finland. While just 19% of those on standard in-center HD were working, 39% of those on home HD, 40% of those with working transplants, and 44% on cycler PD were employed.
Read the abstract » | (added 2011-10-27)
Tags:
-
Antioxidant improves residual kidney function in PD
Four weeks of twice-daily oral N-acetylcysteine, an antioxidant, significantly increased residual kidney function of people on PD in a small study (n=10).
Read the abstract » | (added 2011-10-27)
Tags:
-
Implantable artificial kidney—progress
Three key bits of technology are needed to make an implantable artificial kidney possible: high efficiency membranes to remove water, a way to keep blood from clotting, and a way to mimic the selective action of kidney cells for removing wastes. Progress is occurring in each area.
Read the abstract » | (added 2011-10-27)
Tags: Chronic kidney disease
-
Patients educated about options are more likely to choose home
A new UK study surveyed 118 people with CKD who were not yet on dialysis. Those who were educated about their options were much more likely to plan for home treatment. The most important factor in their choice: fit of a treatment option with the preferred lifestyle.
Read the abstract » | (added 2011-09-29)
Tags: Chronic kidney disease
-
Using L-carnitine instead of sugar for PD fluid
Over time, sugar can harm the peritoneal membrane so it can't be used for PD. L-carnitine is a substance the body needs for energy. In a new rat study, PD fluid with L-carnitine removed as much—or more—water and wastes as sugar-based fluid. The new fluid was well tolerated and did not damage the peritoneum.
Read the abstract » | (added 2011-09-29)
Tags: